Back to REGN
Assenagon Asset Management S.A. → REGN
Assenagon Asset Management S.A. REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$28M
Q3 2026
Peak value
$268.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $268.7M |
| Q4 2025 | $180M |
| Q1 2026 | $160.5M |
| Q2 2026 | $152.7M |
| Q2 2026 | $152.7M |
| Q3 2026 | $28M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $28M | 36.9K | — | — |
| Q2 2026 | $152.7M | 244.9K | — | — |
| Q2 2026 | $152.7M | 244.9K | — | — |
| Q1 2026 | $160.5M | 207.8K | — | — |
| Q4 2025 | $180M | 233.2K | — | — |
| Q3 2025 | $268.7M | 477.8K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B